Champions Oncology appoints Dr. Brian Alexander to board, replacing Dr. Philip Breitfeld

CHAMPIONS ONCOLOGY, INC.

Board accepted resignation of Dr. Philip Breitfeld and appointed Dr. Brian Alexander effective March 24, 2026.
Dr. Alexander is CEO of Valo Health and CEO-Partner at Flagship Pioneering; formerly CEO of Foundation Medicine.
Appointment supports Champions' strategy to integrate patient-derived tumor models with molecular data for AI-driven R&D.
Dr. Breitfeld's resignation was not due to any disagreement with the company's operations or policies.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.